Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Sharma, Satyavan
1990.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
365.
Macpherson, C. N. L.
and
Craig, P. S.
1991.
Parasitic helminths and zoonoses in Africa.
p.
138.
Schmatz, Dennis M.
and
Schaeffer, James M.
1991.
Vol. 26,
Issue. ,
p.
161.
Zahner, Horst
and
Schares, Gereon
1993.
Experimental chemotherapy of filariasis: Comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi.
Acta Tropica,
Vol. 52,
Issue. 4,
p.
221.
Tagboto, S. K.
and
Townson, S.
1996.
Onchocerca volvulusandO. lienalis:the microfilaricidal activity of moxidectin compared with that of ivermectinin vitroandin vivo.
Annals of Tropical Medicine & Parasitology,
Vol. 90,
Issue. 5,
p.
497.
Townson, S.
Hutton, D.
Siemienska, J.
Hollick, L.
Scanlon, T.
Tagboto, S. K.
and
Taylor, M. J.
2000.
Antibiotics andWolbachiain filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol againstOnchocerca gutturosa,Onchocerca lienalisandBrugia pahangi.
Annals of Tropical Medicine & Parasitology,
Vol. 94,
Issue. 8,
p.
801.
Pink, Richard
Hudson, Alan
Mouriès, Marie-Annick
and
Bendig, Mary
2005.
Opportunities and Challenges in Antiparasitic Drug Discovery.
Nature Reviews Drug Discovery,
Vol. 4,
Issue. 9,
p.
727.
Townson, Simon
Ramirez, Bernadette
Fakorede, Foluke
Mouries, Marie-Annick
and
Nwaka, Solomon
2007.
Challenges in drug discovery for novel antifilarials.
Expert Opinion on Drug Discovery,
Vol. 2,
Issue. sup1,
p.
S63.
Mackenzie, Charles D
and
Geary, Timothy G
2011.
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
Expert Review of Anti-infective Therapy,
Vol. 9,
Issue. 5,
p.
497.
Paveley, R. A.
and
Bickle, Q. D.
2013.
Automated Imaging and other developments in whole‐organism anthelmintic screening.
Parasite Immunology,
Vol. 35,
Issue. 9-10,
p.
302.
Halliday, Alice
Guimaraes, Ana F
Tyrer, Hayley E
Metuge, Haelly Mejane
Patrick, Chounna Ndongmo Winston
Arnaud, Kengne-Ouafo Jonas
Kwenti, Tayong Dizzle Bita
Forsbrook, George
Steven, Andrew
Cook, Darren
Enyong, Peter
Wanji, Samuel
Taylor, Mark J
and
Turner, Joseph D
2014.
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
Parasites & Vectors,
Vol. 7,
Issue. 1,
Mbah, Glory Enjong
Ayiseh, Rene Bilingwe
and
Cho-Ngwa, Fidelis
2016.
Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
BMC Infectious Diseases,
Vol. 16,
Issue. 1,
Sharma, Raman
Jayoussi, Ghaith Al
Tyrer, Hayley E.
Gamble, Joanne
Hayward, Laura
Guimaraes, Ana F.
Davies, Jill
Waterhouse, David
Cook, Darren A. N.
Myhill, Laura J.
Clare, Rachel H.
Cassidy, Andrew
Steven, Andrew
Johnston, Kelly L.
Ford, Louise
Turner, Joseph D.
Ward, Stephen A.
and
Taylor, Mark J.
2016.
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
Scientific Reports,
Vol. 6,
Issue. 1,
Njouendou, Abdel J.
Fombad, Fanny F.
O’Neill, Maeghan
Zofou, Denis
Nutting, Chuck
Ndongmo, Patrick C.
Kengne-Ouafo, Arnaud J.
Geary, Timothy G.
Mackenzie, Charles D.
and
Wanji, Samuel
2018.
Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections.
Parasites & Vectors,
Vol. 11,
Issue. 1,
Sjoberg, Hanna T.
Pionnier, Nicolas
Aljayyoussi, Ghaith
Metuge, Haelly M.
Njouendou, Abdel J.
Chunda, Valerine C.
Fombad, Fanny F.
Tayong, Dizzle B.
Gandjui, Narcisse V. T.
Akumtoh, Desmond N.
Chounna, Patrick W. N.
Ndzeshang, Bertrand L.
Lachaud, Sophie
Tekle, Fetene
Quirynen, Ludo
Engelen, Marc
Baeten, Benny
Steven, Andrew
Ward, Stephen A.
Taylor, Mark J.
Wanji, Samuel
Turner, Joseph D.
and
Mitre, Edward
2019.
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models.
PLOS Neglected Tropical Diseases,
Vol. 13,
Issue. 1,
p.
e0006356.
Fombad, Fanny Fri
Njouendou, Abdel Jelil
Ndongmo, Patrick Chounna
Ritter, Manuel
Chunda, Valerine C.
Metuge, Haelly M.
Gandjui, Narcisse Victor T.
Enyong, Peter
Njiokou, Flobert
Hoerauf, Achim
Mackenzie, Charles D.
and
Wanji, Samuel
2019.
Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents.
Parasites & Vectors,
Vol. 12,
Issue. 1,
Ngwewondo, Adela
Scandale, Ivan
and
Specht, Sabine
2021.
Onchocerciasis drug development: from preclinical models to humans.
Parasitology Research,
Vol. 120,
Issue. 12,
p.
3939.
Tagboto, Senyo
and
Orish, Verner
2022.
Drug development for onchocerciasis-the past, the present and the future.
Frontiers in Tropical Diseases,
Vol. 3,
Issue. ,
Ayiseh, Rene Bilingwe
Mbah, Glory Enjong
Manfo, Faustin Pascal Tsague
Kulu, Tessy-Koko
Njotu, Fabrice Ngoh
Monya, Elvis
Ndi, Emmanuel Menang
Tumanjong, Irene Memeh
Mainsah, Evans Ngandung
Sakanari, Judy
Lustigman, Sara
and
Cho-Ngwa, Fidelis
2023.
Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening model.
Parasitology Research,
Vol. 122,
Issue. 7,
p.
1581.